TrialAlzheimer's research & therapy2021

Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial.

Seong-Ho Koh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.